ATR and hepatocellular carcinoma: Several clinical studies are being conducted to explore the effect of ATR inhibitors combined with DNA-damaging therapeutic interventions including radiotherapy or chemotherapy in varied types of tumors.36–38 In this study, ATR inhibitor AZD6738 did not enhance the HCC control rate of radiotherapy.